BREAKING: J&J to Buy Heart Failure Company Abiomed for $16.6B
“The transaction broadens Johnson & Johnson MedTech’s (JJMT) position as a growing cardiovascular innovator, advancing the standard of care in one of healthcare’s largest unmet need disease states: he
Original source: https://rumble.com/v1qwc0y-breaking-j-and-j-to-buy-heart-failure-company-abiomed-for-16.6b.html
